FDA Authorizes Emergency Use of In Vitro Diagnostic for MERS-CoV Detection

Summary

The US Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for an in vitro diagnostic device to detect Middle East Respiratory Syndrome Coronavirus (MERS-CoV), following a determination by the Secretary of Health and Human Services that there is a significant public health emergency.